DE1620456A1 - Verfahren zur Herstellung von 3-Methyl-5-isopropylphenyl-estern - Google Patents
Verfahren zur Herstellung von 3-Methyl-5-isopropylphenyl-esternInfo
- Publication number
- DE1620456A1 DE1620456A1 DE19661620456 DE1620456A DE1620456A1 DE 1620456 A1 DE1620456 A1 DE 1620456A1 DE 19661620456 DE19661620456 DE 19661620456 DE 1620456 A DE1620456 A DE 1620456A DE 1620456 A1 DE1620456 A1 DE 1620456A1
- Authority
- DE
- Germany
- Prior art keywords
- acid
- methyl
- isopropylphenyl
- pyrrolidine
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 3
- 238000002360 preparation method Methods 0.000 title claims description 3
- -1 3-methyl-5-isopropylphenyl esters Chemical class 0.000 title description 9
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 9
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- CPEONABTMRSIKA-UHFFFAOYSA-N 1,4$l^{2}-oxazinane Chemical compound C1COCC[N]1 CPEONABTMRSIKA-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- STUHQDIOZQUPGP-UHFFFAOYSA-N morpholin-4-ium-4-carboxylate Chemical compound OC(=O)N1CCOCC1 STUHQDIOZQUPGP-UHFFFAOYSA-N 0.000 claims description 3
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- 241001480043 Arthrodermataceae Species 0.000 description 4
- 230000037304 dermatophytes Effects 0.000 description 4
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 4
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 3
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 3
- 229960002867 griseofulvin Drugs 0.000 description 3
- ZDUIHRJGDMTBEX-UHFFFAOYSA-N 3-methyl-5-propan-2-ylphenol Chemical compound CC(C)C1=CC(C)=CC(O)=C1 ZDUIHRJGDMTBEX-UHFFFAOYSA-N 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FCLZCOCSZQNREK-UHFFFAOYSA-N Pyrrolidine, hydrochloride Chemical compound Cl.C1CCNC1 FCLZCOCSZQNREK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- XACWJIQLDLUFSR-UHFFFAOYSA-N pyrrolidine-1-carbonyl chloride Chemical compound ClC(=O)N1CCCC1 XACWJIQLDLUFSR-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESC038577 | 1966-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1620456A1 true DE1620456A1 (de) | 1970-04-23 |
Family
ID=7434771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661620456 Pending DE1620456A1 (de) | 1966-03-02 | 1966-03-02 | Verfahren zur Herstellung von 3-Methyl-5-isopropylphenyl-estern |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3457262A (cg-RX-API-DMAC10.html) |
| BE (1) | BE694907A (cg-RX-API-DMAC10.html) |
| CH (1) | CH487886A (cg-RX-API-DMAC10.html) |
| DE (1) | DE1620456A1 (cg-RX-API-DMAC10.html) |
| FR (2) | FR1512900A (cg-RX-API-DMAC10.html) |
| GB (1) | GB1173066A (cg-RX-API-DMAC10.html) |
| NL (1) | NL6703119A (cg-RX-API-DMAC10.html) |
-
1966
- 1966-03-02 DE DE19661620456 patent/DE1620456A1/de active Pending
-
1967
- 1967-02-20 US US617082A patent/US3457262A/en not_active Expired - Lifetime
- 1967-02-22 CH CH253967A patent/CH487886A/de not_active IP Right Cessation
- 1967-02-27 NL NL6703119A patent/NL6703119A/xx unknown
- 1967-03-01 FR FR97010A patent/FR1512900A/fr not_active Expired
- 1967-03-02 BE BE694907D patent/BE694907A/fr unknown
- 1967-03-02 GB GB9905/67A patent/GB1173066A/en not_active Expired
- 1967-05-31 FR FR108547A patent/FR6672M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE694907A (cg-RX-API-DMAC10.html) | 1967-09-04 |
| US3457262A (en) | 1969-07-22 |
| GB1173066A (en) | 1969-12-03 |
| CH487886A (de) | 1970-03-31 |
| FR6672M (cg-RX-API-DMAC10.html) | 1969-02-03 |
| NL6703119A (cg-RX-API-DMAC10.html) | 1967-09-04 |
| FR1512900A (fr) | 1968-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1238478B (de) | Verfahren zur Herstellung von 3-Amino-pyrazin-carbonsaeurederivaten | |
| DE2245560A1 (de) | Verfahren zur herstellung von 4alkoxycarbonyl-2-thiazolinen | |
| DE2308883C3 (de) | 2-Phenylamino-thienylmethyl-imidazoline-(2), Verfahren zur Herstellung derselben und diese enthaltene Arzneimittel | |
| DE1620456A1 (de) | Verfahren zur Herstellung von 3-Methyl-5-isopropylphenyl-estern | |
| DE2131330A1 (de) | Imidazo-[1,2-a]-benzimidazolderivate und Verfahren zur Herstellung derselben | |
| DE1135921B (de) | Verfahren zur Herstellung von heterocyclisch substituierten Morphinanen und deren Salzen | |
| DE1242619B (de) | Verfahren zur Herstellung von neuen Nikotionsaeureestern | |
| DE2141765A1 (de) | 4-chlor-4-thiazolin-2-one und verfahren zu deren herstellung | |
| DE2264903C3 (de) | Piperidinderivate und ihre Herstellung | |
| DE829894C (de) | Verfahren zur Herstellung neuer Derivate von 1, 8-Naphthyridin-4-carbonsaeuren | |
| DE1097998B (de) | Verfahren zur Herstellung neuer 1, 2, 4-Oxadiazole | |
| DE2404924A1 (de) | Ergolinderivate | |
| AT204558B (de) | Verfahren zur Herstellung neuer heterocyclischer Verbindungen | |
| DE2521895A1 (de) | Alpha-amino-2-adamantylessigsaeure und verfahren zu ihrer herstellung | |
| DE69113901T2 (de) | Pyrazolo(1,5-a)pyridine, deren Herstellung und Verwendung. | |
| AT287726B (de) | Verfahren zur Herstellung von neuen 1H-Thieno-[3,2-e]-1,4-diazepin-2-onen sowie ihren N-Oxyden und Salzen | |
| DE1252209B (cg-RX-API-DMAC10.html) | ||
| DE1060375B (de) | Verfahren zur Herstellung cyclischer Aldehyde | |
| DE586068C (de) | Verfahren zur Darstellung von stickstoffhaltigen Derivaten des Anthracens | |
| CH526546A (de) | Verfahren zur Herstellung neuer 3-Phenylpiperidinderivate | |
| DE828102C (de) | Verfahren zur Herstellung von 3-Phenaceturyl-5-dimethyl-thiazolidin-4-carbonsaeure | |
| DE1620971B2 (de) | Verfahren zur Herstellung von Poly furoxanen | |
| AT277474B (de) | Verfahren zur Herstellung neuer Derivate von Bufadienolidglykosiden | |
| CH444884A (de) | Verfahren zur Herstellung neuer basischer 1,3-Dioxane und ihrer Salze | |
| AT215998B (de) | Verfahren zur Herstellung von neuen Hydrazinderivaten |